Valacyclovir
NDC 63187-950, Valacyclovir, tablet, film coated, from Proficient Rx LP.
- Product NDC
- 63187-950
- Status
- Listed
- Labeler
- Proficient Rx LP
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203047
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63187-950 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- VALACYCLOVIR HYDROCHLORIDE1 g/1
Pharmacologic classes
DNA Polymerase Inhibitors [MoA]; Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Nucleoside Analog [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63187-950-04 | 63187095004 | 4 TABLET, FILM COATED in 1 BOTTLE (63187-950-04) |
| 63187-950-06 | 63187095006 | 6 TABLET, FILM COATED in 1 BOTTLE (63187-950-06) |
| 63187-950-10 | 63187095010 | 10 TABLET, FILM COATED in 1 BOTTLE (63187-950-10) |
| 63187-950-14 | 63187095014 | 14 TABLET, FILM COATED in 1 BOTTLE (63187-950-14) |
| 63187-950-20 | 63187095020 | 20 TABLET, FILM COATED in 1 BOTTLE (63187-950-20) |
| 63187-950-21 | 63187095021 | 21 TABLET, FILM COATED in 1 BOTTLE (63187-950-21) |
| 63187-950-30 | 63187095030 | 30 TABLET, FILM COATED in 1 BOTTLE (63187-950-30) |
| 63187-950-60 | 63187095060 | 60 TABLET, FILM COATED in 1 BOTTLE (63187-950-60) |
| 63187-950-90 | 63187095090 | 90 TABLET, FILM COATED in 1 BOTTLE (63187-950-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8794a786-245a-42a3-b33a-9b0ed1dd46ac
Use it
Look up 63187-950 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63187-950 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63187-950. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.